Vanguard Group’s Cyclerion Therapeutics CYCN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $68.4K | Hold |
23,490
| – | – | ﹤0.01% | 4170 |
|
2025
Q1 | $58K | Hold |
23,490
| – | – | ﹤0.01% | 4184 |
|
2024
Q4 | $75.6K | Hold |
23,490
| – | – | ﹤0.01% | 4185 |
|
2024
Q3 | $60.6K | Hold |
23,490
| – | – | ﹤0.01% | 4235 |
|
2024
Q2 | $54K | Hold |
23,490
| – | – | ﹤0.01% | 4285 |
|
2024
Q1 | $75.2K | Hold |
23,490
| – | – | ﹤0.01% | 4266 |
|
2023
Q4 | $78.7K | Sell |
23,490
-17,041
| -42% | -$57.1K | ﹤0.01% | 4325 |
|
2023
Q3 | $139K | Sell |
40,531
-40,638
| -50% | -$139K | ﹤0.01% | 4308 |
|
2023
Q2 | $334K | Sell |
81,169
-1,570,367
| -95% | -$6.47M | ﹤0.01% | 4218 |
|
2023
Q1 | $717K | Hold |
1,651,536
| – | – | ﹤0.01% | 4011 |
|
2022
Q4 | $1.08M | Buy |
1,651,536
+832
| +0.1% | +$546 | ﹤0.01% | 3884 |
|
2022
Q3 | $1.42M | Sell |
1,650,704
-103,449
| -6% | -$88.9K | ﹤0.01% | 3879 |
|
2022
Q2 | $963K | Hold |
1,754,153
| – | – | ﹤0.01% | 4102 |
|
2022
Q1 | $1.95M | Sell |
1,754,153
-116,210
| -6% | -$129K | ﹤0.01% | 3969 |
|
2021
Q4 | $3.22M | Buy |
1,870,363
+438,334
| +31% | +$754K | ﹤0.01% | 3847 |
|
2021
Q3 | $4.4M | Buy |
1,432,029
+8,497
| +0.6% | +$26.1K | ﹤0.01% | 3743 |
|
2021
Q2 | $5.55M | Sell |
1,423,532
-245,607
| -15% | -$958K | ﹤0.01% | 3538 |
|
2021
Q1 | $4.66M | Buy |
1,669,139
+3,959
| +0.2% | +$11K | ﹤0.01% | 3568 |
|
2020
Q4 | $5.1M | Sell |
1,665,180
-54,240
| -3% | -$166K | ﹤0.01% | 3345 |
|
2020
Q3 | $10.5M | Buy |
1,719,420
+597,816
| +53% | +$3.63M | ﹤0.01% | 2760 |
|
2020
Q2 | $6.63M | Sell |
1,121,604
-171,203
| -13% | -$1.01M | ﹤0.01% | 2963 |
|
2020
Q1 | $3.43M | Buy |
1,292,807
+1,182
| +0.1% | +$3.13K | ﹤0.01% | 3132 |
|
2019
Q4 | $3.51M | Sell |
1,291,625
-3,580
| -0.3% | -$9.74K | ﹤0.01% | 3284 |
|
2019
Q3 | $15.7M | Buy |
1,295,205
+174,871
| +16% | +$2.12M | ﹤0.01% | 2592 |
|
2019
Q2 | $12.8M | Buy |
+1,120,334
| New | +$12.8M | ﹤0.01% | 2716 |
|